• Je něco špatně v tomto záznamu ?

Complex metabolic disharmony in PMM2-CDG paves the way to new therapeutic approaches

N. Himmelreich, F. Kikul, L. Zdrazilova, T. Honzik, A. Hecker, G. Poschet, C. Lüchtenborg, B. Brügger, S. Strahl, F. Bürger, JG. Okun, H. Hansikova, C. Thiel

. 2023 ; 139 (3) : 107610. [pub] 20230516

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016983

PMM2-CDG is the most common defect among the congenital disorders of glycosylation. In order to investigate the effect of hypoglycosylation on important cellular pathways, we performed extensive biochemical studies on skin fibroblasts of PMM2-CDG patients. Among others, acylcarnitines, amino acids, lysosomal proteins, organic acids and lipids were measured, which all revealed significant abnormalities. There was an increased expression of acylcarnitines and amino acids associated with increased amounts of calnexin, calreticulin and protein-disulfid-isomerase in combination with intensified amounts of ubiquitinylated proteins. Lysosomal enzyme activities were widely decreased as well as citrate and pyruvate levels indicating mitochondrial dysfunction. Main lipid classes such as phosphatidylethanolamine, cholesterol or alkyl-phosphatidylcholine, as well as minor lipid species like hexosylceramide, lysophosphatidylcholines or phosphatidylglycerol, were abnormal. Biotinidase and catalase activities were severely reduced. In this study we discuss the impact of metabolite abnormalities on the phenotype of PMM2-CDG. In addition, based on our data we propose new and easy-to-implement therapeutic approaches for PMM2-CDG patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016983
003      
CZ-PrNML
005      
20231026105344.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ymgme.2023.107610 $2 doi
035    __
$a (PubMed)37245379
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Himmelreich, Nastassja $u Centre for Child and Adolescent Medicine, Department I, Heidelberg University, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany
245    10
$a Complex metabolic disharmony in PMM2-CDG paves the way to new therapeutic approaches / $c N. Himmelreich, F. Kikul, L. Zdrazilova, T. Honzik, A. Hecker, G. Poschet, C. Lüchtenborg, B. Brügger, S. Strahl, F. Bürger, JG. Okun, H. Hansikova, C. Thiel
520    9_
$a PMM2-CDG is the most common defect among the congenital disorders of glycosylation. In order to investigate the effect of hypoglycosylation on important cellular pathways, we performed extensive biochemical studies on skin fibroblasts of PMM2-CDG patients. Among others, acylcarnitines, amino acids, lysosomal proteins, organic acids and lipids were measured, which all revealed significant abnormalities. There was an increased expression of acylcarnitines and amino acids associated with increased amounts of calnexin, calreticulin and protein-disulfid-isomerase in combination with intensified amounts of ubiquitinylated proteins. Lysosomal enzyme activities were widely decreased as well as citrate and pyruvate levels indicating mitochondrial dysfunction. Main lipid classes such as phosphatidylethanolamine, cholesterol or alkyl-phosphatidylcholine, as well as minor lipid species like hexosylceramide, lysophosphatidylcholines or phosphatidylglycerol, were abnormal. Biotinidase and catalase activities were severely reduced. In this study we discuss the impact of metabolite abnormalities on the phenotype of PMM2-CDG. In addition, based on our data we propose new and easy-to-implement therapeutic approaches for PMM2-CDG patients.
650    _2
$a lidé $7 D006801
650    12
$a vrozené poruchy glykosylace $x genetika $x terapie $x metabolismus $7 D018981
650    _2
$a glykosylace $7 D006031
650    12
$a fosfotransferasy (fosfomutasy) $x genetika $7 D017875
650    _2
$a aminokyseliny $x metabolismus $7 D000596
650    _2
$a lipidy $7 D008055
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kikul, Frauke $u Heidelberg University Biochemistry Center (BZH), Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
700    1_
$a Zdrazilova, Lucie $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a Honzik, Tomáš $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a Hecker, Andreas $u Centre for Child and Adolescent Medicine, Department I, Heidelberg University, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany
700    1_
$a Poschet, Gernot $u Centre for Organismal Studies (COS), Plant Molecular Biology, Heidelberg University, Im Neuenheimer Feld 360, 69120 Heidelberg, Germany
700    1_
$a Lüchtenborg, Christian $u Heidelberg University Biochemistry Center (BZH), Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
700    1_
$a Brügger, Britta $u Heidelberg University Biochemistry Center (BZH), Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
700    1_
$a Strahl, Sabine $u Centre for Organismal Studies (COS), Glycobiology, Heidelberg University, Im Neuenheimer Feld 360, 69120 Heidelberg, Germany
700    1_
$a Bürger, Friederike $u Centre for Child and Adolescent Medicine, Department I, Heidelberg University, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany
700    1_
$a Okun, Jürgen G $u Centre for Child and Adolescent Medicine, Department I, Heidelberg University, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany
700    1_
$a Hansikova, Hana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a Thiel, Christian $u Centre for Child and Adolescent Medicine, Department I, Heidelberg University, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany. Electronic address: christian.thiel@med.uni-heidelberg.de
773    0_
$w MED00006573 $t Molecular genetics and metabolism $x 1096-7206 $g Roč. 139, č. 3 (2023), s. 107610
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37245379 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105339 $b ABA008
999    __
$a ok $b bmc $g 2000481 $s 1203345
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 139 $c 3 $d 107610 $e 20230516 $i 1096-7206 $m Molecular genetics and metabolism $n Mol Genet Metab $x MED00006573
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...